Is Vor Biopharma Inc (VOR) overvalued? · $813.9M cap
Vor Biopharma Inc (VOR) is a biotechnology company listed on NASDAQ.
This page asks whether Vor Biopharma Inc (VOR) looks expensive on cached numbers — not a short thesis.
No cached income statement for VOR, so there is no earnings base to call rich or cheap.
VOR currently screens at market cap $813.9M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next VOR 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the VOR stock page for the full model, not this heading.
Not investment advice.